Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis

SIMPLE SUMMARY: Although twice-daily concurrent chemoradiotherapy for limited-stage small-cell lung cancer (LS-SCLC) is still the standard treatment, this regimen is inconvenient and not universally adopted across different institutions. Therefore, the optimal radiation dose and fractions are still...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wei, Wang, Pang, Ti, Xinyu, Yin, Yutian, Huang, Shigao, Yang, Zhi, Li, Jie, Chai, Guangjin, Lyu, Bo, Li, Zhaohui, Zhou, Yan, Xiao, Feng, Xu, Lin, Shi, Mei, Zhao, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406024/
https://www.ncbi.nlm.nih.gov/pubmed/36010913
http://dx.doi.org/10.3390/cancers14163920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406024/
https://www.ncbi.nlm.nih.gov/pubmed/36010913
http://dx.doi.org/10.3390/cancers14163920

Ejemplares similares